Skip to content

Skype for Youth With Poorly Controlled Diabetes

Improving Health Through SkypeTM: Family-Based Intervention for Teens With Poorly Controlled Diabetes

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02274103
Acronym
SKYPE
Enrollment
92
Registered
2014-10-24
Start date
2010-03-31
Completion date
2012-12-31
Last updated
2014-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Brief summary

Compared family-based skills training (aka, Behavioral Family Systems Therapy) to youth with poorly controlled type 1 diabetes and their parents either face-to-face or over SkypeTM. Examined the differential impact on the youth's adherence to the diabetes medical regimen and the youth's blood sugar control.

Interventions

BEHAVIORALBFST

Family-based skills training.

Sponsors

Oregon Health and Science University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Youth between the ages of 12 and 18 with type 1 diabetes characterized by an HbA1c value great than 9% * Caregivers willing to participate * Family members reading English at 5th grade level * Willing to be randomized.

Exclusion criteria

* Youth with intellectual disability * Parent or youth who doesn't speak English

Design outcomes

Primary

MeasureTime frameDescription
HbA1cChange from Baseline to 3 months and from 3 months to 6 monthsHbA1c values for both intervention groups improved from baseline to 3 months and from 3 months to 6 months.

Secondary

MeasureTime frameDescription
Adherence to diabetes treatment using the Diabetes Self Management Profile (DSMP) (Harris et al, 2001).Change from Baseline to 3 months and from 3 months to 6 monthsDSMP scores for both intervention groups improved from baseline to 3 months and from 3 months to 6 months.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 9, 2026